顺铂耐药-话题@MedSci

#顺铂耐药#

6篇内容 | 1083人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2199621, encodeId=42f7219962114, content=<a href='/topic/show?id=f9e2832202f' target=_blank style='color:#2F92EE;'>#胃癌#</a> <a href='/topic/show?id=cbef6022e4c' target=_blank style='color:#2F92EE;'>#曲妥珠单抗#</a> <a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a> <a href='/topic/show?id=cac61136041f' target=_blank style='color:#2F92EE;'>#改良DOF双周方案#</a>, objectTitle=【论著】| 曲妥珠单抗辅助改良DOF双周方案对顺铂耐药的胃癌患者血清肿瘤标志物及生存率的影响分析, objectType=article, longId=822591, objectId=6530822591a7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=6530822591a7, replyNumber=0, likeNumber=102, createdTime=2024-04-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=6530822591a7, moduleTitle=【论著】| 曲妥珠单抗辅助改良DOF双周方案对顺铂耐药的胃癌患者血清肿瘤标志物及生存率的影响分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6530822591a7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1958239, encodeId=dbb619582390c, content=<a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a>, objectTitle=Cell Death Dis：miR-526b-3p抑制肺癌的顺铂耐药和转移, objectType=article, longId=215572, objectId=d3e22155e24b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3e22155e24b, replyNumber=0, likeNumber=88, createdTime=2022-06-04, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3e22155e24b, moduleTitle=Cell Death Dis：miR-526b-3p抑制肺癌的顺铂耐药和转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3e22155e24b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958238, encodeId=a75419582384f, content=<a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a>, objectTitle=J Exp Clin Cancer Res：顺铂耐药肺癌细胞通过Src / CD155 / MIF功能途径促进肿瘤相关巨噬细胞的M2极化, objectType=article, longId=165304, objectId=95f2165304b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95f2165304b9, replyNumber=0, likeNumber=98, createdTime=2020-03-13, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95f2165304b9, moduleTitle=J Exp Clin Cancer Res：顺铂耐药肺癌细胞通过Src / CD155 / MIF功能途径促进肿瘤相关巨噬细胞的M2极化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95f2165304b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958237, encodeId=f955195823e09, content=<a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a>, objectTitle=CLIN CANCER RES：顺铂耐药的卵巢癌中存在有丝分裂退出异常, objectType=article, longId=150111, objectId=bdf715011151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdf715011151, replyNumber=0, likeNumber=94, createdTime=2019-02-04, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdf715011151, moduleTitle=CLIN CANCER RES：顺铂耐药的卵巢癌中存在有丝分裂退出异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf715011151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958236, encodeId=a09c195823603, content=<a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a>, objectTitle=Sci Rep：卵巢癌对顺铂耐药的新机制, objectType=article, longId=98184, objectId=a25c981840d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a25c981840d, replyNumber=0, likeNumber=88, createdTime=2017-09-01, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a25c981840d, moduleTitle=Sci Rep：卵巢癌对顺铂耐药的新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a25c981840d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958235, encodeId=1f911958235f8, content=<a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a>, objectTitle=新的基因学研究帮助化疗患者摆脱顺铂耐药性的困扰！, objectType=article, longId=78561, objectId=ee77e856177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee77e856177, replyNumber=0, likeNumber=71, createdTime=2017-06-23, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee77e856177, moduleTitle=新的基因学研究帮助化疗患者摆脱顺铂耐药性的困扰！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee77e856177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958234, encodeId=560019582347b, content=<a href='/topic/show?id=9fff10012688' target=_blank style='color:#2F92EE;'>#顺铂耐药#</a>, objectTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, objectType=article, longId=57302, objectId=3c895e302cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c895e302cd, replyNumber=0, likeNumber=72, createdTime=2016-06-17, rootId=0, userName=yeye5224612, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c895e302cd, moduleTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c895e302cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

顺铂耐药

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#胃癌# #曲妥珠单抗# #顺铂耐药# #改良DOF双周方案#

【论著】| 曲妥珠单抗辅助改良DOF双周方案对顺铂耐药的胃癌患者血清肿瘤标志物及生存率的影响分析

2024-04-21发表于陕西省

yeye5224612 (审核中...)

前往app查看评论内容

#顺铂耐药#

Cell Death Dis：miR-526b-3p抑制肺癌的顺铂耐药和转移

2022-06-04

yeye5224612 (审核中...)

前往app查看评论内容

#顺铂耐药#

J Exp Clin Cancer Res：顺铂耐药肺癌细胞通过Src / CD155 / MIF功能途径促进肿瘤相关巨噬细胞的M2极化

2020-03-13

yeye5224612 (审核中...)

前往app查看评论内容

#顺铂耐药#

CLIN CANCER RES：顺铂耐药的卵巢癌中存在有丝分裂退出异常

2019-02-04

yeye5224612 (审核中...)

前往app查看评论内容

#顺铂耐药#

Sci Rep：卵巢癌对顺铂耐药的新机制

2017-09-01

yeye5224612 (审核中...)

前往app查看评论内容

#顺铂耐药#

新的基因学研究帮助化疗患者摆脱顺铂耐药性的困扰！

2017-06-23

yeye5224612 (审核中...)

前往app查看评论内容

#顺铂耐药#

Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现

2016-06-17

科室
- - 订阅+
  - 更多科室
工具
服务